Latuda 60 mg Oral Tablet
RxNorm 1431237
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1431237 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Latuda 60 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Latuda 60 mg Oral Tablet
(Atom ID: 6369510)
SYPrescribable
Synonym (SY):
Latuda 60 mg Oral Tablet
(Atom ID: 5484596)
SBDPrescribable
Semantic Branded Drug (SBD):
Lurasidone hydrochloride 60 mg Oral Tablet [Latuda]
(Atom ID: 12368799)
Patient Education
Lurasidone
Lurasidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and children 13 years of age and older. It is also used to treat depression in adults and children 10 years of age and older with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lurasidone is also used along with lithium (Lithobid) or valproate (Depacon) to treat depression in adults with bipolar disorder. Lurasidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.